ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

HELD Hellenic Dynamics Plc

2.80
-0.10 (-3.45%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hellenic Dynamics Plc LSE:HELD London Ordinary Share GB00BRXCFB77 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10 -3.45% 2.80 2.70 2.90 2.90 2.80 2.90 279,838 15:38:42
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Gen Contractor-nonres Bldgs 0 -4.86M -0.0004 -70.00 350.84M
Hellenic Dynamics Plc is listed in the Gen Contractor-nonres Bldgs sector of the London Stock Exchange with ticker HELD. The last closing price for Hellenic Dynamics was 2.90p. Over the last year, Hellenic Dynamics shares have traded in a share price range of 2.25p to 22.00p.

Hellenic Dynamics currently has 12,530,000,000 shares in issue. The market capitalisation of Hellenic Dynamics is £350.84 million. Hellenic Dynamics has a price to earnings ratio (PE ratio) of -70.00.

Hellenic Dynamics Share Discussion Threads

Showing 1051 to 1074 of 2975 messages
Chat Pages: Latest  47  46  45  44  43  42  41  40  39  38  37  36  Older
DateSubjectAuthorDiscuss
09/6/2023
08:48
Good tweets.
pirates4
09/6/2023
08:46
"which will see Hellenic Dynamics harnessing its scale and low cost operating model in a way that it anticipates will accelerate revenue generation and provide an opportunity to its customers. Such a strategy has not yet seen in the cannabis space to date. This modified strategy and operating model, details of which are set out below, is different and disruptive in comparison to the Company's peer group and is designed to match the rapidly evolving regulated medical cannabis market in Europe."

harnessing scale....accelerate revenue generation....provide opportunity to its customers......designed to match the rapidly evolving regulated cannabis market.

It's a pity the original RNS wasn't fuller, with more meat on the bone.

As I previously posted, the market was also anticipating a very different update (one in which, to a degree, it would have sold into anyway) and not the curve ball we got.

I think there has been an overreaction and the shares are looking oversold and still with a potential raft of upbeat news and checkpoints to come, I have added.

oakridge
09/6/2023
08:34
Growing specific strains for distributors or companies who are heavy on the research and clinical findings, but who are light on the ability to scale and produce quantities at competitive levels. That perfectly sums up companies like CEL and other more pharmaceutically minded companies, who do not stand a chance of growing competitively without either significant investment or outsourcing to those who can do it at scale in a lower cost country.

Interesting.

oakridge
09/6/2023
08:23
We've been told in previous RNS' that the off take agreements the company has into Germany are good for around 2 years of supply (using HELD's phased approach).

Now, it could be that with the shelving of EU-GMP (which, at this point, wouldn't add huge margins to the sale price), they propose to go bigger, sooner.

Phasing up sooner might perhaps be possible with the money they've saved (both on the GMP process and in the successful procurement of s/h equipment).....which might relate back to Haffner's post, which someone on here highlighted.

The RNS wasn't particularly well communicated granted but amid the dust, I am seeing some sense emerge from the shift in strategy and my guess is we'll find the company back in front of the market before too long with more info.

AIMO ADYOR etc

oakridge
09/6/2023
08:22
They will Oakridge, they will
solarno lopez
09/6/2023
08:18
Everton - there's a much longer 'talk to camera' missive by D.R. on the company website. Follow the link off HELD's twitter thread.

The shares should start to find some support from here imo. They are on a 30% sale at present.

Will post more on the strategy shortly....but if you read my post from the other day where I talk about the lack of capacity other cannabis companies have (people like CEL and so on), it seems I might have been on the money when I suggested a potential route could be for HELD to become a vast 'contract' grower....

More to follow..

oakridge
09/6/2023
08:15
Edited below..
oakridge
09/6/2023
08:15
Cheers Everton
ashleyjv
09/6/2023
08:10
Oh, and they've revamped the website including the addition of biographies of all of the Advisory Board (KF is there now)
everton448
09/6/2023
07:59
The company has just out a thread out on Twitter in the last few minutes which is definitely worth a read. More info than the RNS (in fact surprised it didn't form part of the RNS!)
everton448
07/6/2023
17:55
Pirates47 Jun '23 - 17:51 - 877 of 877 (Filtered)
oakridge
07/6/2023
17:51
I didn't say you did, they didn't for a reason maybe
pirates4
07/6/2023
17:50
Each to their own, Extrader....and I certainly wish you well. It's at least good to read someone else's research and reasoning, succinctly put, which is far from a given on advfn.

You may have made the right call, but in general, I'm more inclined to buy or add when there is an element of fear, uncertainty and/or disappointment around a share, as apposed to selling. And the reverse of that is true, of course.

However, we are back to a very, very low mkt valuation...and whilst you make a number of interesting points and observations, all of which carry a potential cloud, conversely it is also possible all of those points could 'come good'....in which case you could also view the period ahead as having a number of positive news events lined up.

If we were sitting at a heady valuation, I'd be more inclined to follow.....but we are not, and the shares are down, fresh off a news event which wasn't the one an expectant market was anticipating. So the shares are back on sale.

It could be the license, if indeed it hasn't yet been granted, is about to be so.

It could be the company is about to announce a further sales agreement.

It could be cultivation timelines are not too far off the original timeframe (if indeed the company originally anticipated first harvest July - Sept).

It could be the linkedIn ad you referred to by Haffner, is indeed for HELD, but instead of thinking it might be to fit out our earliest P1 area, perhaps it is for accelerated growth into P11....which they've decided to go for, sooner than anticipated, at the expense of going through the EU-GMP?

Again, just speculation.

I agree however, that we shouldn't be have to hypothesise so much and there should be less known unknowns etc as you say.

Ironically the quip you made about cannabis and chocolate might in fact bear some connection to the company, if, as I idly speculated last night, the company might try to go for mass volume production and not just for the medicinal sector specifically. Again...that is just hypothesising on my part, but it did come up in conversation with other PI's last night as we aimed to see some sense and order in the dust!

And finally, it is indeed odd that Katherine Fleming hasn't been added to the company website. Just as some may think it odd that there was, for a period yesterday, some aggressive buying.

Keep in touch, and for better or for worse we will see what transpires.

All the best.

AIMO ADYOR etc

oakridge
07/6/2023
16:45
.."The rns yesterday did not mention Katherine.."

I never said it did.

I was observing -in the context of the poor website - (have you looked at it?) that it hadn't been updated to include her.

Which seems odd in view of her heading up an $8.5 billion foundation.

Which is why I described her omission (and Winnifroth's) as 'curiosities/loose ends'.

Which are tbh peripheral, compared with some of the other, more substantive issues I raised.

HTH

extrader
07/6/2023
16:30
I suppose she's Greek or fluent in Greek language. Also has a huge funding business which would see expand in the US. Art and drugs go hand in hand.
pirates4
07/6/2023
16:28
The rns yesterday did not mention Katherine
pirates4
07/6/2023
15:36
Hi all

I'd be OK with the pardonable confusion over dates, if they worked to PI advantage...but they don't :

(1).."currently on track to have its first cultivation underway in late summer 2023" - that suggests no real revenue until Q4 calendar year.
What will this mean for HELD's cash position?

(2) I have a question about the status of HELD's operational licence, 1 of the 2 it needs : From RNS dated 2nd August 2021:

"Greek legislation describes a two-stage licensing process; the first being an installation licence and the second an operational licence.... Hellenic holds a facility installation licence (the "Licence"), granted on 24 October 2019, which permits it to construct and establish a cannabis processing and production facility. Hellenic is in the final stages of completing the necessary works to apply for an operational licence."

So they had the installation licence but not the operational licence (surely getting it would be newsworthy and RNSable?).

The last mention appears to be here

hxxps://ukinvestormagazine.co.uk/standard-reversal-hellenic-dynamics-cultivates-licence

which said (as at 7/12/2022) ..."The company still has to obtain an operations licence in Greece so that it can sell the cannabis flowers and extract that it will produce..."

(3) Whilst trawling HELD's website [a fairly poor 'work in progress', btw] and re-visiting RNS's, I looked again at the 26 Jan RNS appointing Carl Haffner as a consultant on the Development Team.

Firstly, Davinder specifically highlights .."Having previously successfully established an EU-GMP cultivation facility, his appointment will provide additional support to ensure our targets are met." That hasn't aged well. When exactly did the strategy change?

Secondly, I didn't do my usual Companies House search back in Jan, because Haffner wasn't a Board appointment.

My bad : the histories of QE Global Limited (06232015), 2C Install Limited/prev. QEG Install (09391357), Power by Light Limited (11129598), Avida Global (11540240), Avida Global Systems (11547291) and maybe others don't inspire confidence.

Thirdly : on revisiting Haffner's linked in hxxps://www.linkedin.com/feed/update/urn:li:activity:7069600923433476096/, I was puzzled to see this message, from a week ago :

.."I'm collaborating with a client who is based in Europe and is currently seeking a comprehensive list of Medical Cannabis Cultivation items.

These essentials include, but are not limited to:

Indoor Cultivation equipment
Propagation supplies
Fertilisers and nutrients
Pest management solutions
Harvesting and processing equipment
Trimming (Ideally Mobius) equipment

Regardless of whether these items are new or used, our aim is to source these critical tools to streamline and bolster their cultivation operations..."

If this is for HELD going forward, how to square with yesterday's update, which suggests that this has already been done ?

..", since the Company's last business update [Jan 2023}, Hellenic Dynamics has managed to secure significant discounts from its equipment suppliers and has also managed to secure unused second hand equipment, where possible, to keep costs as low as possible while ensuring all equipment is of the highest and modern standards throughout the facility..."

The Jan 2023 update [3 days before Haffner's appointment] appeared to suggest that all was on track back then, including for the GMP work that HELD has now decided not to pursue :

.." Phase one of the fit-out and process implementation strategy for the facility is well underway . All cultivation and propagation activities will be in line with Good Agricultural and Collection Practices for Medicinal Plants ("GACP") requirements and the post-harvest completion area will be in line with EU-Good Manufacturing Practice ("EU-GMP") requirements..."

In any event, if they're only looking to source equipment NOW, this adds weight to the argument that HELD is significantly behind its growing/harvesting schedule.

[Aside : Haffner's obv an entrepreneurial type : his more recent outreach is for "an intriguing opportunity in a burgeoning market that intersects both the coffee and cannabis sectors"....."a venture that combines the beloved ritual of sipping coffee with the therapeutic properties of cannabis.."

Is this also HELD ? If so, you read it here first!] ;-> ;-> ;->

Finally, two curiosities / loose ends:

(1) Despite joining the Advisory Board nearly 3 months ago, Katherine Fleming doesn't feature on the website...and she's a remarkably Establishment figure ..President and CEO of the J. Paul Getty Trust, the international cultural and philanthropic institution, overseeing its 1,500 employees and US$8.5 billion endowment fund.

(2) Shareprophets hasn't written anything about HELD, AFAICS : Winnifroth normally has a go at start-ups, whether justified or not.

I wonder whether her appointment and his silence are because they're both Hellenophiles ?

If you've got this far, you won't be surprised to learn that I've sold out today.

This is all a cathartic 'note to self' , since I've decided that there are too many 'known unknowns' and 'unknown unknowns' for me at this time.

GLA and ATB

extrader
07/6/2023
15:05
Pirates47 Jun '23 - 14:12 - 870 of 870 (Filtered)
oakridge
07/6/2023
14:12
The weather is right for seasoning
pirates4
07/6/2023
13:39
I’m going off the quotes from the company
Its quite plain and simple to understand the information from the company itself

Mid summer first harvest has now been put back to first harvest late summer

There for all to see

judijudi
07/6/2023
12:51
Judi. I'm not insisting there isn't a delay. Indeed, there might be. I am however addressing and trying to make sense of HOW the company has set out its targets and the language it has used around dates, quarters and so on.

What I HAVE said, is that I personally - rightly or wrongly - always interpreted first harvest as falling into the quarter of July-September. Others, like you, thought April-June.

Those with an interest, or if they are so motivated, can always contact the company to get the definitive answer.

Cheerio for now and do remember to put the kettle on and take 5.

oakridge
07/6/2023
12:45
No wonder we are confused.

Watch the video in the header. Even in this interview, DR gives two different answers to effectively the same question in the space of a minute.

That interview was published on Dec 13th 2022.

From approx 4.20..

"We're looking to get our products cultivated within Q2 of THIS year" (?!?!)

then..

When are you expecting to have your first sales?

"So we're looking to get our first crop out in patients hands in Q2 of NEXT year"

How do I post a shoulder shrug imoji?

oakridge
07/6/2023
12:41
As I’ve pointed out several times the company yesterday announced a few months delay in cultivation
The market hates delays
I wonder what our German customer thinks of it?
Probably gone elsewhere
Nothing whatsoever ambiguous in the rns of yesterday
Mid summer has been moved to late summer
Price gets hammered on the delay
It’s not Rocket Science even though some are struggling to understand (or don’t want to admit to the delay) that it’s a significant delay in the first harvest and the first target set by the company
It’s there in plain English for all to see

judijudi
07/6/2023
12:16
Certainly agree on the communication skills Extrader.

A proof reader on the latest RNS wouldn't have gone a miss either.

Judi - didn't realise I was. Just trying to address the confusion others have expressed on certain dates. Glad I managed to point to what you were unable to see in your own post however! :O) Do calm down and have a cup of tea dear!

oakridge
Chat Pages: Latest  47  46  45  44  43  42  41  40  39  38  37  36  Older

Your Recent History

Delayed Upgrade Clock